What’s the Difference: Gram-Positive vs Gram-Negative?

Gram-positive and gram-negative bacteria differ primarily in their cell wall structure, and that single architectural difference affects how they cause disease, how they respond to antibiotics, and how dangerous they can be. The distinction comes from a staining technique developed in the 1880s: gram-positive bacteria turn purple, gram-negative bacteria turn pink. But the stain is really just revealing a fundamental difference in how these organisms are built.

The Cell Wall Is the Core Difference

Gram-positive bacteria have a thick outer wall made of a mesh-like material called peptidoglycan, ranging from 30 to 100 nanometers thick with many stacked layers. This thick wall absorbs and holds onto the purple crystal violet dye used in gram staining, which is why these bacteria appear purple under a microscope.

Gram-negative bacteria have a much thinner peptidoglycan layer, only a few nanometers thick and just one to a few layers deep. That thin wall can’t retain the purple dye, so these bacteria pick up a second pink counterstain instead. But gram-negative bacteria compensate for their thinner wall with something gram-positive bacteria lack entirely: a second outer membrane.

The Outer Membrane Changes Everything

The outer membrane of gram-negative bacteria is not a typical biological membrane. Instead of having the same type of fat molecule on both sides, it has an unusual asymmetric structure with standard phospholipids on the inner face and a large, complex molecule called lipopolysaccharide (LPS) coating the outer face. LPS is made of three parts: a fatty anchor that locks it into the membrane, a core sugar chain that maintains the membrane’s structural integrity, and a repeating sugar chain on the surface that interacts directly with the environment.

This outer membrane acts as a powerful shield. It blocks entry of harmful substances like bile salts in the gut, which is one reason gram-negative bacteria thrive in the intestines. It also creates a second compartment between the two membranes, called the periplasm, which functions almost like a miniature organ. The periplasm handles protein folding and quality control, houses environmental sensors, contains structural scaffolding, and even sequesters enzymes that would be toxic if they floated freely inside the cell.

Gram-positive bacteria have no outer membrane and no true periplasm. Instead, they embed molecules called teichoic acids into their thick peptidoglycan wall. Some of these are anchored to the cell membrane below, while others are woven directly into the peptidoglycan itself. These teichoic acids help regulate the cell wall’s electrical charge and play roles in cell division and attachment to surfaces.

Why Gram-Negative Bacteria Are Harder to Treat

That extra outer membrane makes gram-negative bacteria naturally resistant to many antibiotics. The membrane physically blocks large molecules from getting in. As a general rule, chemicals larger than about 600 daltons (a measure of molecular weight) cannot penetrate it. Some critical antibiotics, like vancomycin, are far too large at around 1,400 daltons to cross this barrier, which is why vancomycin works well against gram-positive infections but is useless against gram-negative ones.

Smaller antibiotics can still get through, but only by passing through porins, which are water-filled protein channels embedded in the outer membrane. Porins allow passive diffusion of small, water-soluble molecules like sugars and nutrients, and certain antibiotics hitchhike through the same channels. Beta-lactams (the family that includes penicillin), tetracycline, and fluoroquinolones all rely on porins to reach their targets inside the cell. Gram-negative bacteria can develop resistance by mutating these porins or reducing their number, essentially closing the doors that drugs need to enter.

Gram-positive bacteria, with their peptidoglycan wall exposed directly to the environment, are generally more accessible to antibiotics. Drugs can penetrate the wall more easily, which is why many common antibiotics were originally developed to target gram-positive infections.

Different Toxins, Different Infections

The two groups tend to make people sick through different mechanisms. Gram-negative bacteria carry LPS as a built-in component of their outer membrane, and when the bacteria die and break apart, that LPS is released. The immune system reacts intensely to free LPS, which acts as an endotoxin. This can trigger fever, rapid heart rate, dropping blood pressure, and in severe cases, septic shock with organ failure. The toxin isn’t something the bacteria actively secrete; it’s simply part of their structure that becomes dangerous when released in large quantities.

Gram-positive bacteria more commonly produce exotoxins, which are proteins they actively build and release. These exotoxins cause a wide range of specific diseases. Superantigens produced by staph and strep bacteria can trigger toxic shock syndrome by causing an exaggerated immune response, flooding the body with inflammatory signals. Other exotoxins break down tissue directly, as in gas gangrene caused by certain clostridia. Still others hijack nerve signaling, as in tetanus and botulism. Some gram-negative bacteria also produce exotoxins, but this is more characteristic of gram-positive species.

Common Examples of Each

Many of the bacteria you’ve heard of fall neatly into one category or the other. Among gram-positive bacteria, the most familiar pathogens include Staphylococcus aureus (staph infections, MRSA), Streptococcus pyogenes (strep throat, scarlet fever), Clostridium difficile (C. diff colitis), Clostridium tetani (tetanus), and Clostridium botulinum (botulism).

On the gram-negative side, major human pathogens include E. coli (urinary tract infections, food poisoning), Klebsiella (pneumonia, bloodstream infections), Pseudomonas aeruginosa (wound and lung infections, especially in hospitals), and Acinetobacter (hospital-acquired infections). Gram-negative bacteria are a growing concern in healthcare settings because their built-in resistance mechanisms make infections harder to treat, and many strains have acquired additional resistance to last-resort antibiotics.

Bacteria That Don’t Fit Neatly

Not every bacterium stains cleanly as one type or the other. Some species, like certain Actinomyces and Acinetobacter, are considered “gram-variable,” meaning they can appear positive, negative, or mixed depending on growth conditions. Older bacterial cultures also tend to lose peptidoglycan integrity, causing gram-positive cells to stain pink and look gram-negative. And some medically important bacteria sidestep the system entirely. Mycoplasma species have no cell wall at all, making gram staining useless. Chlamydia and Rickettsia are too small for the stain to work reliably.

These exceptions are worth knowing because they explain why doctors don’t rely on gram staining alone. It’s a fast, useful first step that helps narrow down what type of infection someone has and which antibiotics might work, but it’s typically followed by more specific tests to identify the exact organism involved.